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Striving towards the ideal cardiac functional assessment 
strategy: the contribution of tissue Doppler, strain and 
strain rate imaging
JC MOOLMAN-SMOOK, PA BRINK
Summary
in	 cardiac	 research,	 a	 major	 goal	 of	 prevention	 of	 cata-
strophic	 events	 by	 risk-factor	 management	 and	 earlier	
detection	 has,	 in	 recent	 years,	 led	 to	 a	 proliferation	 of	
imaging	 modalities,	 moving	 us	 from	 old-fashioned	 chest	
X-ray	 through	 increasingly	 sophisticated	 approaches	 such	
as	magnetic	 resonance	 imaging	 (MRi)	 and	multi-slice	 fast	
computer-aided	tomography	(CT)	scanning.	Today,	we	have	
the	option	of	using	a	vast	array	of	invasive	and	non-invasive	
approaches,	with	diverse	technical	underpinnings,	to	assess	
various,	and	often	overlapping	aspects	of	cardiac	function.	
Tissue	Doppler	 imaging	 (TDi)	and	 the	 related	applica-
tions	 of	 strain	 and	 strain	 rate	 imaging	are	new	 technolo-
gies	that	are	now	being	evaluated	in	the	realm	of	practical	
patient	care,	and	 the	underlying	principles	remind	us	 that	
cardiac	 contractility	 is	 a	 reflection	 of	 the	 integration	 of	
muscle	 fibre	architecture,	mechanics	and	metabolism.	TDi	
is	the	first	technology	that	allowed	imaging	of	motion	within	
the	myocardial	wall	rather	than	that	of	the	blood	pool,	and	
permits	analysis	of	velocities	and	accelerations	 from	ultra-
sonic	 scatterers	 in	muscle.1	Since	 its	 inception,	 it	has	been	
used	 to	 evaluate	both	new	 cardiac	 functional	parameters	
as	well	 as	 conventional	 function;	 for	 some	 of	 these,	TDi	
has	proven	the	superior	imaging	modality,	while	for	others	
it	 offers	 only	 incremental	 information	 over	 conventional	
approaches.
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From the single fibre to the whole heart and 
segmental function 
The efficiency of the cardiac pump depends on the effective 
contraction and relaxation (contractility) of the muscle walls 
and the topology and geometry of the cardiac chambers. It is 
not a homogeneous muscle mass, but its molecular constitution 
varies; this includes both normal variation and variation arising 
from disease states, which presumably affects contractility. These 
differences in constitution and architecture are seen between the 
endocardium, mesocardium and epicardium, between the left 
and the right ventricle as well as within different localities in 
these chambers, between young and older individuals, between 
normotensive and hypertensive states, and between diseases 
such as ischaemic heart disease and cardiomyopathies.
Our perceptions of cardiac contractility have to a great 
extent been shaped by isolated heart muscle fibre experiments 
(for overview see references 2 and 3). By extrapolating these 
findings to the whole ventricle, a number of concepts have 
evolved.
● Velocity and power of contraction in single fibres are 
directly related to fibre length at the beginning of contrac-
tion (also known as the Frank-Starling law). For the whole 
heart, this is extrapolated to consider the geometry of the 
heart, so that velocity and power of contraction are generally 
correlated with ventricular volume or diameter at the end of 
diastole. 
● During contraction in single-fibre experiments, the increas-
ing tension is taken up by in-line elastic components and 
possibly by elastic components operating in parallel. Force 
is generated by contractile elements called sarcomeres, and 
involves thickening in some places and thinning in others. 
There is an isometric phase during which there is no fibre 
shortening, and is equivalent to the isovolumic phase, while 
the shortening phase correlates with the ejection phase of 
systole. Similar equivalents exist for early and late diastole.
● The tension and velocities generated in either single fibres 
or the whole heart can be manipulated by physical param-
eters such as starting length or load, and pharmacological 
and metabolic means. 
Terminology from such single-fibre experiments has led, at 
the level of the whole heart, to concepts of the rate of pressure 
development (dP/dt), wall tension, preload, afterload, end-systo-
lic pressure–volume relationship (elastance), inotropic state, 
etc. Measurement of fractional shortening and ejection fraction 
became a ‘surrogate’ for pump function in the absence of direct 
information regarding pressure development from all the non-
invasive diagnostic methods. 
Furthermore, anatomical and histological studies have taught 
us that the muscle of the heart is layered in a spiral fashion. 
While subendocardial fibres, which have a mostly lengthwise 
orientation, are mainly responsible for longitudinal shortening 
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of the heart, subepicardial fibres, with a more circumferen-
tial orientation are mainly responsible for radial (short-axis) 
contraction. Ejection is therefore not just the result of inward 
pressure mounted from concentric forces when these muscle 
layers start to tense, but, very importantly, longitudinal shorten-
ing of the muscle fibres combined with these concentric forces 
results in a twisting effect, like a wet cloth being wrung out. Of 
course, the reverse happens in diastole. During cardiac contrac-
tion, the apex remains fixed, while the base of the heart ‘screws 
down’ onto the apex, with, as we have learnt from TDI, a veloc-
ity gradient running from base to apex.
Reasoning from an anthropological principle, this whole 
sequence is purposeful, and in aspiring to assess myocardial 
function, we should strive to take account of these known facts. 
The ideal approach to assessing cardiac function would offer 
non-invasive measurement of the velocity and rate of accelera-
tion of myocardial regions, as well as the moment-to-moment 
changes in chamber pressures. Currently no imaging modality 
can offer these features, but TDI, strain and strain rate imaging 
do at least address the issue of velocity and rate of acceleration 
of myocardial regions, and can give an indirect indication of 
tension and force development derived from measurements of 
conformational changes within muscle.
Principles of tissue Doppler imaging
The normal myocardial fibre architecture described earlier 
gives rise to differences in velocities of contraction in distinct 
myocardial regions, which can be detected by TDI. In contrast to 
conventional Doppler echocardiography, which produces blood 
flow data dependent on velocities of elements within the blood, 
TDI quantitatively measures velocities of elements (‘scatterers’) 
within the myocardium itself. Relative to blood flow, muscle 
movement (0.06–0.24 ms) is 10 times slower and returns high-
intensity echoes (40 decibels higher than blood).4 By means of a 
so-called ‘wall filter’, and facilitated by the highest capacity for 
frame rates of any current imaging modality, TDI can discrimi-
nate between muscle movement and blood flow, and can detect 
short-lived motion usually undetectable by the human eye. 
This allows TDI to record transient events in the cardiac cycle, 
including the isovolumic stages and post-systolic shortening.
As with blood-flow Doppler, TDI accuracy depends on align-
ment of the probe with the elements generating the velocity, 
ie, with the direction of wall motion. However, in contrast to 
conventional grey-scale echocardiography, velocity data does 
not depend on the amplitude of the reflected signal, but rather 
on shifts in frequency. Therefore, because it is not absolutely 
dependent on a clearly defined border, and because data on 
myocardial movement can be obtained from an extremely small 
segment (1 3 1 mm on GE Healthcare’s Vivid-7), even subopti-
mal echocardiographic images can be assessed with TDI.4
Two types of TDI are currently available, pulse-wave and 
colour TDI. The first allows immediate analysis of muscle 
movement, which displays peak velocities at single locations 
(with particular functional implications), but does not allow 
comparison across myocardial regions. On the other hand, 
colour TDI can be used to detect velocity differences between 
the endo- and epicardium, from which the myocardial velocity 
gradient can be derived. 
An important limitation in interpreting such TDI results 
is that the velocities measured are determined not only by 
contraction and relaxation of the fibres themselves, but also by 
movement of the heart within the chest and the twisting motion 
of the heart when it contracts (so-called translational effects). 
Newer applications of colour TDI make use of deformation 
measurements (strain and strain rate) where particular myocar-
dial velocities are correlated with other local velocities, making 
them relatively independent of translational effects and facili-
tating functional evaluations across myocardial regions. With 
colour TDI, strain and strain rate, a mass of imaging data are 
collected reasonably fast in a formulated manner. These images 
are then analysed off-line, which, although time consuming, has 
advantages and disadvantages.4,5 
Strain	and	strain	rate	imaging
In strain and strain rate imaging, myocardial strain is defined 
as the deformation of a section of myocardium in comparison 
with its original size and form. In a sense, shortening fraction 
and ejection fraction represent a gross form of strain; simi-
larly, myocardial strain is dimensionless and usually shown as 
a percentage. Strain rate refers to the deformation of the region 
of muscle over time. 
Strain rate can currently be measured in only one dimen-
sion, which implies that the sonar beam must be parallel or 
perpendicular to the direction of deformation. If it were possi-
ble, three-dimensional strain imaging would be able to measure 
deformation in nine directions, which would then include the 
effect of shearing forces, namely, forces operating in directions 
not aligned with the main force. 
Currently, this is not possible with any echocardiography 
techniques, but is feasible with MRI. However, MRI is time 
consuming, acquisition of data takes longer and facilities are 
less readily available.6 Moreover, the strain measured in colour 
TDI reflects ‘natural strain’,6 which is based on instantaneous 
dimensions. It is not dependent on knowledge of the initial 
dimension, and is different from the strain measured by MRI, 
which is in essence Lagrangian strain. Although these two types 
of strain are similar at the level of 5 to 10% deformation, they 
are quite different at high percentages. In TDI-based strain 
imaging, strain rate can be derived from tissue velocities, while 
strain is calculated as the spatial integral of strain rate. 
Strain and strain rate imaging are new developments and the 
technology is currently being further refined. TDI-based strain 
and strain rate are extremely sensitive to the direction of the 
transducer. This drawback has been overcome by another new 
and related technique, namely, speckle-tracking imaging (STI), 
which is used to measure tissue velocity, strain and strain rate. 
In STI, speckles that are constant features within the myocardial 
image are tracked frame by frame, and yield information about 
muscle deformation in two orthogonal directions, both longitu-
dinal and radial dimensions.7
If strain and strain rate imaging could be extended to three-
dimensional analysis, it would make this modality as informative 
as MRI, but with the added advantage of easier data collection. 
The applications of strain and strain rate imaging in day-to-day 
patient care are still being explored. While strain correlates with 
changes in stroke volume, and therefore with global contractil-
ity, strain rate seems to carry the same information as rate of 
pressure development in the ventricles (dP/dt).8 Currently, its 
most significant application is in the assessment of patients for 
cardiac resynchronisation therapy. In contrast, the applications 
of particularly pulse-wave TDI in routine clinical practice are 
well established.
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Current clinical applications of TDI, strain and 
strain rate imaging
Performance of any new technology should be compared with 
existing gold standards before its practical utility and its ability 
to improve on or replace existing technologies can be interpret-
ed, and, accordingly, the application of TDI to measure numer-
ous aspects of systolic and diastolic function has been assessed 
over the past decade or so. 
Longitudinal shortening of the subendocardial fibres of 
entire cardiac walls, which is the primary event in cardiac 
contraction, is reflected in the displacement of mitral and tricus-
pid valve annuli, and this displacement is therefore considered 
a good surrogate for global left or right ventricular function. It 
is typically assessed by averaging mitral or tricuspid annular 
displacement velocity measured by pulse-wave TDI at two or 
more of the corners of valve annuli (lateral, septal, anterior and 
inferior) during systole and diastole. This value derived from 
mitral annular displacement in systole (Sa) has been shown 
to correlate well with left ventricular ejection fraction (LVEF) 
determined by two-dimensional echocardiography (Sa < 7 cm/s 
indicates LVEF < 45%).9
Diastolic function has conventionally been assessed by 
blood flow through the mitral valve in conventional Doppler 
echocardiography. However, these Doppler flow variables are 
highly load and volume dependent, making them inaccurate 
measures of diastolic function for some patients, such as those 
with hypertrophic cardiomyopathy (HCM) or mitral valve 
disease. By contrast, early diastolic mitral annular displacement 
velocity (Ea) may be less dependent on preload.10,11 The ratio of 
conventional Doppler early diastolic mitral valve flow (E) to Ea 
(E/Ea) of ≥ 10 has been shown to correlate well with mean left 
ventricular end-diastolic pressure ≥ 15 mmHg, irrespective of 
the LVEF or the presence of mitral regurgitation.12,13 
Another TDI parameter, namely tissue Doppler (TD) MPI, 
which is related to the myocardial performance index (MPI) 
or Tei14 index, a Doppler-derived blood-flow measure of global 
ventricular function, has also been found to inversely correlate 
well with end-systolic elastance in an animal study.15 However, 
TD MPI is sensitive to loading conditions, and further studies 
in humans would be required to determine whether the loading 
conditions typical in human patients would preclude the utility 
of this approach. 
The interrelationship of velocities generated from the distinct 
myocardial regions is often perturbed due to cardiac disease 
states well before manifesting via the conventional clinical or 
Doppler echocardiography parameters. Therefore, TDI meas-
urement of systolic and diastolic function of both ventricles 
and atria can be used for earlier diagnosis, prognosis and risk 
stratification in increasing numbers of cardiac disorders, in 
some respects adding, although incrementally, to conventional 
parameters, and in other respects, facilitating non-invasively, 
measurements which otherwise would have required invasive 
approaches. Some of these are discussed briefly below.
Non-invasive	assessments
In addition to facilitating non-invasive estimation of filling pres-
sures during assessment of left ventricular diastolic dysfunction, 
TDI may provide a more accessible and less invasive approach 
for measurement of right ventricular as well as atrial function. 
Right ventricular function: To date, estimation of right 
ventricular function, which has prognostic and clinical value 
for heart failure and post-MI patients, has not been accurate-
ly assessable by conventional echocardiographic approaches. 
This is mainly due to imaging difficulties ensuing from right 
ventricular anatomy, so that cardiac MRI or CT imaging, which 
are generally less widely available, and introduce additional 
limitations, have had to be relied on. TDI may offer a fast, non-
invasive approach for assessing right ventricular function, 
as peak systolic tricuspid annular velocity (Sa) < 11.5 cm/s 
has been shown to correlate well with right ventricular EF < 
45%, and has been used in prognostication of heart failure 
patients.16,17
Atrial function: Atrial electrical function can only be precise-
ly measured by invasive electrophysiological means, while 
atrial mechanical function is usually determined from atrial 
volume-derived indices, which are load and observer dependent. 
However, lately, a number of studies have demonstrated that TDI 
is a non-invasive, reliable and easy approach to estimate total 
atrial electrical activation time18 as well as mechanical func-
tion, independent of left ventricular function.19,20 Specifically, 
peak atrial systolic mitral annular velocity correlates well 
with left atrial systolic fractional area change and fractional 
volume change during atrial systole,21 while peak regional atrial 
contraction velocity [V(A)] may be a better reflection of atrial 
mechanical function than transmitral atrial velocity assessed by 
conventional Doppler echocardiography.22
Early	diagnosis
Preclinical genetic disease: Early identification of individuals 
at risk of genetically mediated cardiac disease is often desirable 
to facilitate implementation of preventive or remedial measures, 
however, variability in the age of onset and subtlety of preclini-
cal features, as measured conventionally, may make clinical 
identification difficult. In addition, genetic identification can be 
complicated by heterogeneity of the causal genes and mutations. 
Because TDI can identify subtle signs of systolic and diastolic 
dysfunction, which cannot be detected by conventional two-
dimensional or blood-flow Doppler echocardiography, it can be 
used to identify cardiac involvement in sufferers of inherited 
disorders with a myocardial component, such as Friedreich’s 
ataxia, various muscular dystrophies and myotonic dystrophy, at 
an early stage of the disease.23
For example, the variability in the extent of left ventricular 
wall thickening and the age of onset of hypertrophy makes 
clinical identification of individuals at risk of developing HCM 
problematical. In HCM mutation carriers, both systolic and 
early diastolic velocities are markedly lower than in non-carriers 
(Ea < 13.5 cm/s), even before the development of hypertrophy. 
These reductions in velocities can be used to predict mutation 
carriers in HCM families, allowing cost-effective follow-up and 
intervention (Moolman-Smook, Brink, unpublished data).24-27
Another example is Fabry’s disease, which often presents 
with exclusively cardiac manifestations in female carriers and 
in male carriers of particular genetic mutations.28,29 Preclinical 
detection of cardiac involvement is highly desirable, as early 
enzyme replacement therapy can prevent the development of 
arrhythmic and thromboembolytic complications; however, 
conventional non-invasive approaches such as ECG, two-dimen-
sional echocardiography and cardiac magnetic resonance imag-
ing (cMRI) cannot do so.30 
On the other hand, when compared to non-carriers, Fabry’s 
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mutation carriers demonstrate marked reduction in TDI systolic 
and early diastolic mitral annular velocity, measured at lateral 
and septal corners of the mitral annulus, irrespective of the 
extent of left ventricular hypertrophy or other systemic manifes-
tations.31 In female Fabry’s mutation carriers, such findings may 
indicate the need for invasive assessment of cardiac involve-
ment; on the other hand, the efficacy of enzyme replacement 
therapy can be monitored non-invasively by TDI.32
Early graft rejection: Cardiac transplant rejection is diffi-
cult to detect non-invasively at an early stage because of the 
non-specificity of conventional echocardiographic findings. 
However, in children with orthotopic heart transplants, TDI 
demonstrated a dramatic decrease in tricuspid (but not mitral) 
systolic and early diastolic velocities at three to six months 
before terminal graft failure. This has lead to the suggestion 
that bi- or tri-annual TDI examinations rather than annual inva-
sive catheterisation and angiography may be a more efficient 
approach to survey for graft impairment.33,34
Differential	diagnosis
Although most conditions that affect myocardial function 
manifest with reduced myocardial velocities, a number of stud-
ies have demonstrated that various TDI indices, sometimes in 
conjunction with conventional clinical criteria, can provide 
discriminatory information for making differential diagnoses. 
Constrictive physiology: For instance, in both restrictive 
cardiomyopathy and constrictive pericarditis, the heart manifests 
with abnormal left ventricular filling patterns; however, differ-
entiating the two conditions is crucial for appropriate treatment. 
Respiratory variation in mitral and pulmonary flow on conven-
tional Doppler echocardiography can differentiate constrictive 
pericarditis patients from those with restrictive cardiomyopathy 
in some but not all cases. However, when also using a peak 
TDI Ea of ≥ 8.0 cm/s, accuracy of diagnosis can be increased.35 
Hypertrophic states: Similarly, differentiation of physio-
logical hypertrophy, such as that seen in athlete’s heart, from 
pathological hypertrophy seen in disease states such as hyper-
tension or hypertrophic cardiomyopathy, has implications for 
patient management and therapy. However, distinguishing these 
states by morphological information derived from conventional 
echocardiography is not clear-cut. TDI reveals that the long-axis 
systolic and early diastolic velocities are decreased in cases of 
pathological hypertrophy, but not in physiological hypertrophy. 
The best differentiation of pathological hypertrophy (due to 
HCM, hypertensive heart disease) from physiological hypertro-
phy (athlete’s heart) was provided by a mean systolic annular 
velocity < 9 cm/s.36 Furthermore, patients with non-obstructive 
left ventricular hypertrophy due to HCM demonstrate greater 
heterogeneity of peak annular velocities, as determined from 
the median, lateral, inferior and anterior mitral annuli, which 
can discriminate this disease state from left ventricular hyper-
trophy due to hypertension.36,37 Similar discrimination between 
left ventricular thickening due to cardiac amyloidosis versus 
other causes of left ventricular hypertrophy can be made by a 
characteristically jagged myocardial velocity profile derived 
from TDI data.38
Prognostication
Because TDI mitral annular velocities predominantly measure 
the long-axis contraction of the ventricle, they reflect the func-
tionality of the subendocardial myofibres, which are particularly 
prone to disturbance by disease conditions. The extent of these 
disturbances, as reflected by altered velocities, is often predic-
tive of the extent of the underlying condition, and therefore TDI 
myocardial velocities are useful predictors of outcome, adding 
incremental value to conventional prognostic indicators in a 
variety of cardiac conditions.39 A number of studies have shown 
that patients with hypertension, ischaemic heart disease, valvu-
lar heart disease, heart failure, diabetes and obstructive sleep 
apnea who present with an increased E/Ea ratio (> 20) have a 
significantly increased risk of adverse cardiac events.40-42
Predicting responders to cardiac resynchronisation therapy: 
Biventricular pacing is considered a promising technique for 
the treatment of congestive heart failure and dilated cardio- 
myopathy. Patients are selected for this treatment predominantly 
on the basis of a wide QRS. However, the therapy succeeds 
because it improves left ventricular mechanical synchrony, and 
therefore selection of patients on the basis of mechanical func-
tion of the myocardium may be more rational. Prepacing colour 
TDI assessment of 12 left ventricular segments is used to assign 
a dyssynchrony index for systolic function, which has proven 
very useful for predicting responders and non-responders to 
cardiac resynchronisation therapy (CRT).43 The TDI-derived 
dyssynchrony index has proven more useful than displacement 
or strain mapping44 although being comparable to velocity-
encoded MRI,45 and facilitates cost-effective CRT by reducing 
the percentage of non-responders. TDI is also useful to define 
the degree and location of mechanical improvement subsequent 
to CRT, and can be used to guide pacemaker optimisation when 
CRT has proven less than optimal.46
Prediction of preserved contractile function in MI patients: 
Defining the degree of preserved myocardial function is clini-
cally important after acute myocardial infarction. A TDI-derived 
peak systolic velocity at the mitral annulus of > 7.5 cm/s can be 
used to predict preserved global left ventricular systolic function 
with 79% sensitivity and 88% specificity in individuals who 
have suffered acute myocardial infarction.47
Furthermore, although the extent of the infarct can be 
defined by delayed-enhancement cMRI, such facilities are not 
always accessible. The absence of a TDI-measured positive 
pre-ejection velocity wave, which originates between ventricu-
lar activation and aortic valve opening48 correlates well with 
myocardial infarction-induced transmural necrosis, and there-
fore with absence of viability of myocardium.49 Similarly, TDI-
based strain rate imaging can be used to differentiate between 
transmural [peak systolic strain rate (SRs) > −0.59 s-1] and non-
transmural infarcts.50
In addition, quantitative pulsed-wave TDI assessment during 
a low-dose dobutamine challenge can differentiate between 
stunned, hibernating and irreversibly dysfunctional regions by 
the degree of reduction in regional myocardial wall velocities.51 
However, dobutamine strain rate imaging may be more accurate 
for identifying hibernating myocardium.52
Conclusion
TDI and the related applications of strain and strain rate imag-
ing allow excellent quantitative assessment, specifically of 
focal myocardial function and are therefore second to none 
for estimation of diastolic function, optimal identification of 
individuals for cardiac resynchronisation therapy and early 
identification of sufferers of certain inherited cardiac disorders 
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in the absence of genetic testing. TDI-related approaches have 
also turned out to be on a par with existing techniques for the 
non-invasive, indirect (by proxy) estimation of parameters 
pertaining to tension and force development, and only time will 
tell whether TDI will replace existing approaches for measuring 
these parameters. Certainly, for myocardial disease, colour TDI, 
strain and strain rate imaging are invaluable for opening up new 
possibilities to understanding disease pathology, and further 
technological development of these modalities, including STI, 
should be watched with interest.
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